Ovagen research in Canada investigates the ovarian tissue-specific epigenetic regulatory properties of this Khavinson peptide bioregulator. Ovagen is derived from ovarian tissue and belongs to the family of short peptide bioregulators studied for their effects on ovarian follicular cell gene expression, steroidogenesis pathway regulation, and the biology of ovarian aging. Canadian reproductive biology researchers and gerontology labs study Ovagen to understand how ovarian-derived peptide bioregulators interact with chromatin in follicular cells and granulosa cells to regulate ovarian function gene expression.
Granulosa Cell Biology Research
Granulosa cells of the ovarian follicle express FSH receptors, aromatase (CYP19A1), and LH receptors — key genes for estrogen biosynthesis and follicular maturation. With aging, epigenetic changes reduce expression of these follicular function genes, contributing to declining ovarian reserve and reproductive capacity. Canadian reproductive aging researchers use Ovagen to study whether ovarian-derived peptide bioregulators can modulate granulosa cell gene expression through chromatin interaction in aged follicular cell models.
Ovarian Aging Research
Ovarian aging is characterized by declining follicular reserve, reduced granulosa cell function, and altered gonadotropin sensitivity. Canadian gerontology researchers use Ovagen to investigate the epigenetic basis of ovarian aging and whether tissue-specific peptide bioregulators can restore aspects of youthful ovarian gene expression in aged ovarian cell research models.
Sourcing Ovagen in Canada
Research-grade Ovagen is available from EhBuddy Peptides in Canada. Lab-tested for purity. For laboratory research use only.
